Suguna Rachakonda PhD, MBA

Suguna Rachakonda, PhD, MBA has over 11 years of experience in small molecule drug discovery in various therapeutic areas. She spent a year at United Therapeutics and 10 years at Pharmasset Inc. (acquired by Gilead Sciences). Suguna was a key contributor to the discovery and development of multiple clinical candidates for antiviral diseases including the recently marketed Hepatitis C drug Sovaldi. She was responsible for leading multiple outsourcing project development teams. Suguna is an inventor on 10 patents. Prior to joining CCI, Suguna was Director of Technology Commercialization at Kent State University leading all aspects of innovation management and commercialization. Suguna received a Ph.D. in Organic Chemistry from University of Hyderabad, India. Subsequently she was a post-doctoral fellow at Tulane University. She received an MBA in Finance from Stern School of Business, New York University.